In a press release published on July 10, 2019, the European Chemicals Agency (ECHA) announced that endocrine disrupting properties will be added to four phthalates currently on the EU Authorization List. These substances are:
- bis(2-ethylhexyl) phthalate (DEHP) (CAS 117-81-7)
- benzyl butyl phthalate (BBP) (CAS 85-68-7)
- dibutyl phthalate (DBP) (CAS 84-74-2)
- diisobutyl phthalate (DIBP) (CAS 84-69-5)
Earlier, in 2011 and 2012, these four phthalates were identified as substances of very high concern (SVHCs) and added to the Authorization List for being toxic to reproduction. Now, they have also been identified as SVHCs “due to endocrine disrupting properties with effects on human health.” DEHP is “also identified for its effects on the environment.” A public consultation on the draft amendment took place between December 2018 and March 2019. In December 2018, the European Commission also adopted a decision to restrict the four substances in consumer products (FPF reported).
Read more
ECHA (July 10, 2019). “Endocrine disrupting properties to be added for four phthalates in the Authorisation List.”
Emma Davies (July 11, 2019). “ECHA recommends amending authorization list for endocrine-disrupting phthalates.” Chemical Watch
